Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.78M Buy
+3,716
New +$1.9M 0.03% 917
2025
Q3
Sell
-1,009
Closed -$317K 2990
2025
Q2
$317K Sell
1,009
-5,327
-84% -$1.6M 0.01% 1391
2025
Q1
$1.93M Buy
6,336
+2,614
+70% +$879K 0.1% 273
2024
Q4
$1.24M Sell
3,722
-2,818
-43% -$956K 0.1% 198
2024
Q3
$2.18M Buy
6,540
+5,573
+576% +$2.12M 0.16% 128
2024
Q2
$398K Sell
967
-372
-28% -$147K 0.03% 786
2024
Q1
$541K Buy
+1,339
New +$471K 0.07% 446
2023
Q4
Sell
-1,717
Closed -$416K 1893
2023
Q3
$416K Buy
+1,717
New +$439K 0.07% 508
2023
Q2
Sell
-1,904
Closed -$358K 1653
2023
Q1
$358K Buy
+1,904
New +$394K 0.08% 511
2022
Q4
Sell
-1,762
Closed -$277K 1349
2022
Q3
$277K Buy
+1,762
New +$281K 0.07% 562
2021
Q3
Sell
-1,719
Closed -$304K 908
2021
Q2
$304K Buy
+1,719
New +$297K 0.1% 357

Other funds holding MEDP

XTX Topco's MEDP Position: Q1 2026 in Review

XTX Topco opened a new position in Medpace (MEDP) in Q1 2026: 3,716 shares worth $1.78M. The stake represents 0.03% of the portfolio and ranks #917 among its holdings. This is a return to the name: XTX Topco previously reported a position in MEDP as recently as Q2 2025.

XTX Topco first reported a position in MEDP in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.18M in Q3 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • XTX Topco held 3,716 shares of Medpace worth $1.78M as of Q1 2026.
  • Medpace was a new XTX Topco position in Q1 2026.
  • Medpace made up 0.03% of XTX Topco's portfolio in Q1 2026, its #917 holding.
  • XTX Topco first reported a position in Medpace in Q2 2021 and has held it in 11 quarters since.
  • XTX Topco's Medpace position peaked at $2.18M in Q3 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.